
Mid Europa backs Walmark
Mid Europa Partners has acquired a 50% stake in Czech dietary supplements manufacturer Walmark from the company's founders.
The GP commented that it hopes to capitalise on the growing consumer health and over-the-counter medicines markets in Central Europe. It added that the business will pursue add-on acquisitions to broaden its geographic footprint and product portfolio.
Company
Walmark was founded in 1990 as an export business focused on the information technology trade and household utensils. The company started trading pharmaceuticals in 1993 before fully focusing on the sector in 2001. Today, Walmark manufactures dietary supplements in a purpose-built production plant in Třinec.
The company has two fully-owned sister companies, Aminostar and Profitness, as well as eight foreign subsidiaries in Europe, including Bulgaria, France, Hungary, Latvia, Lithuania, Poland, Romania and Slovakia.
The company's latest turnover figure was €97.1m. It employs 882 people.
People
Director Michelle Capiod, partner Matthew Strassberg, associate director Robert Chmelar and associate Martin Zita worked on the deal for Mid Europa. Adam Walach is co-founder of Walmark.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater